by
Lisa Chamoff, Contributing Reporter | July 19, 2021
From the July 2021 issue of HealthCare Business News magazine
“This increases diagnostic confidence and can envision dense breast better,” said Samir Parikh, global vice president of research and development and clinical affairs for Hologic.
Pairing 3D imaging with elastography can also accurately measure tumor size and ensure clear margin definition in preoperative settings, Parikh said.
Ad Statistics
Times Displayed: 185365
Times Visited: 4652 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
In January 2021, the company announced the MACH 20 for general and specialty imaging, including breast.
In the screening space, December 2020, the company received FDA clearance for its Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
“This triage and decision support software focuses on how we categorize and prioritize cases based on complexity,” Parikh said.
There were also advances in the biopsy and surgery space. Last August, Hologic announced improvements for its Brevera Breast Biopsy solution, which allows providers to do vacuum-assisted tissue acquisition with real-time imaging verification and advanced post-biopsy handling in one, integrated system.
This “simplifies handling while maintaining the core integrity,” with a disposable needle and reusable device driver
“You can sterilize the driver to simplify storage and improve waste management,” Parikh said.
In November 2020, Hologic launched its PERL Ring Localization Device. Placed up to a few days before breast surgery, it provides a suture-like flexible tail without the drawbacks of traditional stiff wire-localizations. It provides real-time visual and tactile feedback designed to minimize the risk of migration, Parikh said.
After acquiring Faxitron Bioptics in 2018, Hologic introduced the Faxitron CT Specimen Radiography System to the marketplace in January 2020. This 3D CT system is designed to help achieve better surgical outcomes and improve intraoperative specimen margin assessment by providing data from all three axes, beyond tomosynthesis. During 3D reconstruction, the automatic metal artifact correction minimizes interference from metal clips and markers.
iCAD
In March, iCAD received FDA approval for ProFound AI Version 3.0 for digital breast tomosynthesis (DBT). The new version of the software offers up to a 10% improvement in specificity and up to 40% faster processing times compared to previous versions of the software.
